Inventor · disambiguated record
David James Edmonds
Also filed as: EDMONDS DAVID · EDMONDS DAVID J · EDMONDS DAVID JAMES
19 granted patents·15 pending applications·122 citations·filing 2012–2025
94Inventor score
Top patents by PatentIndex Score
34 records- 0198US10851081B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Dec 1, 2020·12 cites·19 claims
- 0297US11512070B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Nov 29, 2022·11 cites·16 claims
- 0397US10208019B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2017·Granted Feb 19, 2019·50 cites·26 claims
- 0496US10934279B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Mar 2, 2021·9 cites·16 claims
- 0596US10683281B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jun 16, 2020·8 cites·30 claims
- 0696US10676465B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jun 9, 2020·8 cites·30 claims
- 0794US12378230B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Aug 5, 2025·1 cites·20 claims
- 0894US10669259B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2018·Granted Jun 2, 2020·13 cites·31 claims
- 0988US12319669B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Jun 3, 2025·0 cites·21 claims
- 1087US2025340544A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2025·Application pending·0 cites
- 1186US11858916B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jan 2, 2024·2 cites·20 claims
- 1284US11065249B2Diacylglycerol acyl transferase 2 inhibitorPFIZER·Filed 2020·Granted Jul 20, 2021·1 cites·30 claims
- 1383US11471458B2Diacylglycerol acyl transferase 2 inhibitorPFIZER·Filed 2020·Granted Oct 18, 2022·1 cites·17 claims
- 1483US2025257052A1Glp-1 receptor agonists and uses thereofPFIZER·Filed 2025·Application pending·0 cites
- 1582US11802121B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2022·Granted Oct 31, 2023·0 cites·20 claims
- 1681US12331041B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Jun 17, 2025·0 cites·16 claims
- 1777US2025270196A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2025·Application pending·0 cites
- 1874US8802688B2Substituted acetyl-coa carboxylase inhibitorsDOW ROBERT LEE·Filed 2012·Granted Aug 12, 2014·4 cites·16 claims
- 1972US2021163455A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2021·Application pending·0 cites
- 2069US9394285B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Jul 19, 2016·1 cites·6 claims
- 2169US2024391908A1Metabolites of glp1r agonistsPFIZER·Filed 2024·Application pending·0 cites
- 2267US2025059171A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2363US9278953B2Antagonists of prostaglandin EP3 receptorPFIZER·Filed 2014·Granted Mar 8, 2016·1 cites·14 claims
- 2462US2024150334A1Hsd17b13 inhibitors and/or degradersPFIZER·Filed 2023·Application pending·0 cites
- 2561US2024109915A1Novel acc inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 2660US12065434B2Metabolites of GLP1R agonistsPFIZER·Filed 2021·Granted Aug 20, 2024·0 cites·21 claims
- 2759US2014323730A1Substituted acetyl-coa carboxylase inhibitorsPFIZER·Filed 2014·Application pending·0 cites
- 2853US2022193063A1Metabolites of glp1r agonistsPFIZER·Filed 2021·Application pending·0 cites
- 2950US2022387402A1Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseasesPFIZER·Filed 2020·Application pending·0 cites
- 3050US2015336958A1Substituted acetyl-coa carboxylase inhibitorsPFIZER·Filed 2015·Application pending·0 cites
- 3148US2015112068A1Substituted acetyl-coa carboxylase inhibitorsPFIZER·Filed 2015·Application pending·0 cites
- 3245US2023405002A1Combinations of diacylglycerol acyltransferase 2 inhibitors and acetyl-coa carboxylase inhibitorPFIZER·Filed 2021·Application pending·0 cites
- 3345US2023045419A1Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine SaltPFIZER·Filed 2020·Application pending·0 cites
- 3430US9738626B2Antagonists of prostaglandin EP3 receptorPFIZER·Filed 2015·Granted Aug 22, 2017·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when David James Edmonds files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →